Colorectal Cancer Therapeutics Market Report

Global and Region Colorectal Cancer Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：186
  • REPORT CODE：GMM909615
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Colorectal Cancer Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Colorectal Cancer Therapeuticsmarket, defines the market attractiveness level of Colorectal Cancer Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Colorectal Cancer Therapeutics industry, describes the types of Colorectal Cancer Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Colorectal Cancer Therapeutics market and the development prospects and opportunities of Colorectal Cancer Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Colorectal Cancer Therapeutics market in Chapter 13.

    By Player:

    • Sumitomo Dainippon Pharma

    • Jiangsu Chia-Tai Tianqing

    • Onyx

    • Eli Lilly

    • Hutchison MediPharma

    • Taiho Pharma

    • Merck KGaA

    • Suzhou Zelgen Biopharmaceuticals

    • Sanofi

    • Bristol-Myers Squib

    • Amgen

    • Bayer

    • Array BioPharma

    • Jiangsu Hengrui Medicine

    • Regeneron

    • Takeda

    • Roche

    By Type:

    • Diagnostics

    • Therapeutics

    By End-User:

    • Hospitals

    • Clinic

    • Research institutions

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Colorectal Cancer Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Colorectal Cancer Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Colorectal Cancer Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Colorectal Cancer Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Colorectal Cancer Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Colorectal Cancer Therapeutics Consumption (2017-2022)

    • 7.2 United States Colorectal Cancer Therapeutics Consumption (2017-2022)

    • 7.3 Europe Colorectal Cancer Therapeutics Consumption (2017-2022)

    • 7.4 China Colorectal Cancer Therapeutics Consumption (2017-2022)

    • 7.5 Japan Colorectal Cancer Therapeutics Consumption (2017-2022)

    • 7.6 India Colorectal Cancer Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Colorectal Cancer Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Colorectal Cancer Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Colorectal Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Colorectal Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Colorectal Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Colorectal Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Colorectal Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Colorectal Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Colorectal Cancer Therapeutics Consumption Forecast (2022-2028)

    9 Global Colorectal Cancer Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Colorectal Cancer Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Colorectal Cancer Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research institutions Consumption and Growth Rate (2017-2022)

    10 Global Colorectal Cancer Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research institutions Consumption Forecast and Growth Rate (2022-2028)

    11 Global Colorectal Cancer Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Colorectal Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Colorectal Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Colorectal Cancer Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Colorectal Cancer Therapeutics Market Competitive Analysis

    • 14.1 Sumitomo Dainippon Pharma

      • 14.1.1 Sumitomo Dainippon Pharma Company Details

      • 14.1.2 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product and Service

    • 14.2 Jiangsu Chia-Tai Tianqing

      • 14.2.1 Jiangsu Chia-Tai Tianqing Company Details

      • 14.2.2 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product and Service

    • 14.3 Onyx

      • 14.3.1 Onyx Company Details

      • 14.3.2 Onyx Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Onyx Colorectal Cancer Therapeutics Product and Service

    • 14.4 Eli Lilly

      • 14.4.1 Eli Lilly Company Details

      • 14.4.2 Eli Lilly Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eli Lilly Colorectal Cancer Therapeutics Product and Service

    • 14.5 Hutchison MediPharma

      • 14.5.1 Hutchison MediPharma Company Details

      • 14.5.2 Hutchison MediPharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hutchison MediPharma Colorectal Cancer Therapeutics Product and Service

    • 14.6 Taiho Pharma

      • 14.6.1 Taiho Pharma Company Details

      • 14.6.2 Taiho Pharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Taiho Pharma Colorectal Cancer Therapeutics Product and Service

    • 14.7 Merck KGaA

      • 14.7.1 Merck KGaA Company Details

      • 14.7.2 Merck KGaA Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck KGaA Colorectal Cancer Therapeutics Product and Service

    • 14.8 Suzhou Zelgen Biopharmaceuticals

      • 14.8.1 Suzhou Zelgen Biopharmaceuticals Company Details

      • 14.8.2 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi Colorectal Cancer Therapeutics Product and Service

    • 14.10 Bristol-Myers Squib

      • 14.10.1 Bristol-Myers Squib Company Details

      • 14.10.2 Bristol-Myers Squib Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Product and Service

    • 14.11 Amgen

      • 14.11.1 Amgen Company Details

      • 14.11.2 Amgen Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Amgen Colorectal Cancer Therapeutics Product and Service

    • 14.12 Bayer

      • 14.12.1 Bayer Company Details

      • 14.12.2 Bayer Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bayer Colorectal Cancer Therapeutics Product and Service

    • 14.13 Array BioPharma

      • 14.13.1 Array BioPharma Company Details

      • 14.13.2 Array BioPharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Array BioPharma Colorectal Cancer Therapeutics Product and Service

    • 14.14 Jiangsu Hengrui Medicine

      • 14.14.1 Jiangsu Hengrui Medicine Company Details

      • 14.14.2 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product and Service

    • 14.15 Regeneron

      • 14.15.1 Regeneron Company Details

      • 14.15.2 Regeneron Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Regeneron Colorectal Cancer Therapeutics Product and Service

    • 14.16 Takeda

      • 14.16.1 Takeda Company Details

      • 14.16.2 Takeda Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Takeda Colorectal Cancer Therapeutics Product and Service

    • 14.17 Roche

      • 14.17.1 Roche Company Details

      • 14.17.2 Roche Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Roche Colorectal Cancer Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Colorectal Cancer Therapeutics

    • Figure Colorectal Cancer Therapeutics Picture

    • Table Global Colorectal Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Colorectal Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Colorectal Cancer Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Colorectal Cancer Therapeutics Consumption by Country (2017-2022)

    • Figure United States Colorectal Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Colorectal Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Colorectal Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Colorectal Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Colorectal Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Colorectal Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Colorectal Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Research institutions Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research institutions Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Colorectal Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Colorectal Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Sumitomo Dainippon Pharma (Foundation Year, Company Profile and etc.)

    • Table Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product and Service

    • Table Jiangsu Chia-Tai Tianqing (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product and Service

    • Table Onyx (Foundation Year, Company Profile and etc.)

    • Table Onyx Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Onyx Colorectal Cancer Therapeutics Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Colorectal Cancer Therapeutics Product and Service

    • Table Hutchison MediPharma (Foundation Year, Company Profile and etc.)

    • Table Hutchison MediPharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hutchison MediPharma Colorectal Cancer Therapeutics Product and Service

    • Table Taiho Pharma (Foundation Year, Company Profile and etc.)

    • Table Taiho Pharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taiho Pharma Colorectal Cancer Therapeutics Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Colorectal Cancer Therapeutics Product and Service

    • Table Suzhou Zelgen Biopharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Colorectal Cancer Therapeutics Product and Service

    • Table Bristol-Myers Squib (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squib Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squib Colorectal Cancer Therapeutics Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Colorectal Cancer Therapeutics Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Colorectal Cancer Therapeutics Product and Service

    • Table Array BioPharma (Foundation Year, Company Profile and etc.)

    • Table Array BioPharma Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Array BioPharma Colorectal Cancer Therapeutics Product and Service

    • Table Jiangsu Hengrui Medicine (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product and Service

    • Table Regeneron (Foundation Year, Company Profile and etc.)

    • Table Regeneron Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Colorectal Cancer Therapeutics Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Colorectal Cancer Therapeutics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Colorectal Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Colorectal Cancer Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US